Macrolide combination antibiotic therapy should be prudently considered in complicated CAP cases and in regions with low macrolide susceptibility.
Shih
Hsin-I
HI
Department of Emergency Medicine, National Cheng Kung University Hospital, No. 138 Sheng Li Road, Tainan City, 704, Taiwan. n506594@mail.hosp.ncku.edu.tw.
Hsu
Hsiang-Chin
HC
Department of Emergency Medicine, National Cheng Kung University Hospital, No. 138 Sheng Li Road, Tainan City, 704, Taiwan.
Chi
Chih-Hsien
CH
Department of Emergency Medicine, National Cheng Kung University Hospital, No. 138 Sheng Li Road, Tainan City, 704, Taiwan.
Ko
Wen-Chien
WC
Division of Infectious Diseases, Department of Internal Medicine, National Cheng Kung University Hospital, Tainan City, Taiwan.
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D017714:Community-Acquired Infections / Q000188:drug therapy*; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D006801:Humans; D018942:Macrolides / Q000008:administration & dosage / Q000627:therapeutic use*; D008826:Microbial Sensitivity Tests; D018410:Pneumonia, Bacterial / Q000188:drug therapy* / Q000382:microbiology
D000900:Anti-Bacterial Agents; D018942:Macrolides